A recent study suggests that universal influenza vaccines could potentially avert 3 billion infections and 826,000 deaths annually, assuming 50% vaccination coverage among children under 18 worldwide. Led by Lucy Goodfellow from the London School of Hygiene and Tropical Medicine, the research employed a modeling analysis to assess health and economic impacts across 186 countries. Vaccination of children aged 0 to 10 years proved most effective. Economic models indicated that while NGIVs might be cost-effective in high-income countries, low-income countries would need significantly lower prices for these vaccines to be feasible.

Source: PLOS Medicine